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The reflex sympathetic dystrophy syndrome (RSD) is a neurogenic pain syndrome that is 
characterized by pain, vasomotor and dystrohic changes and often motor impairments. Although the 
exact pathogenesis of RSD is unknown, for long the sympathetic nervous system was thought to 
play a dominant role and pharmacological and surgical sympathectomies have been a mainstay in 
treatment procedures. However, there is growing evidence of a pivotal role of C- and A8-fibres in 
the aetiology of RSD. These fibres subserve a dual sensory-effector function. Besides the initiation 
of afferent impulses, they release neuropeptide mediators that cause a peripheral neurogenic 
inflammatory reaction and central neuroplastic reactions. Brachial plexus blockade (BPB) with local 
anaesthetic drugs interferes with the conduction of action potentials along both sympathetic efferents 
and the somatosensory C- and AS-afferents and therefore seems a potential treatment modality in 
RSD. The aim of this study was to draw attention on this regional anaesthetic technique that is not 
commonly used in RSD. In this study six patients with severe RSD of an upper extremity in varying 
stages were treated with BPB in the multidisciplinary setting of an out-patient rehabilitation clinic 
with a follow-up of 12 to 21 months. The study was not placebo controlled. Three patients 
responded well. In these cases the treatment interval varied from 3 to 6 months, one case had RSD 
stage 1 and the two others stage 2. Three patients showed poor response. In one of these patients the 
initial effect was good but due to an infection at the insertion site of the catheter BPB had to be 
discontinued. The other two poor-responders had treatment intervals of 7 and 25 months and both 
had stage 3 RSD. We conclude that there is theoretical and clinical support to further evaluate the 
effect of BPB as a treatment modality in the early stages of RSD.
Axillare Armplexusblockage beim sympathischen Reflexdystrophie-Syndrom
Das sympathische Reflexdystrophie-Syndrom (reflex sympathetic dystrophy syndrome -  RSD) ist 
ein neurogenes Schmerzsyndrom mit den Merkmalen Schmerz, vasomotorische und dystrophische 
Veränderungen und häufig auch motorische Schäden. Wenngleich die genaue Pathogenese des RSD 
nicht bekannt ist, wurde lange von einer dominanten Rolle des sympathischen Nervensystems 
ausgegangen; pharmakologische und chirurgische Sympathektomien haben deshalb einen festen 
Platz im therapeutischen Vorgehen. Jedoch gibt es zunehmend Belege für eine zentrale Rolle der C- 
und A-Delta-Nervenfasern in der Ätiologie des RSD. Diese Fasern haben eine sensorisch- 
effektorische Doppelfunktion. Neben der Auslösung afferenter Impulse setzen sie Neuropeptid- 
Mediatoren frei, die eine periphere neurogene Entzündungsreaktion und zentrale neuroplastische 
Reaktionen verursachen. Die Armplexusblockade mit Lokalanästhetika greift in die Weiterleitung
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von Aktionspotentialen sowohl in den sympathischen efferenten Fasern als auch den somatosensor- 
ischen afferenten C- und A-Delta-Fasern ein und bietet sich daher als potentieller Therapieansatz 
beim RSD an. Mit der vorliegenden Studie soll auf diese Lokalanasthesiemethode aufmerksam 
gemacht werden, die in der Behandlung des RSD nicht gängig ist. Im Rahmen der Studie wurde an 
6 Patienten, die verschiedene Stadien eines schweren RSD einer oberen F.xtremiUil aufwiesen, im 
multidisziplinären Setting einer ambulanten Rehaklinkik eine Blockade des Plexus braehialis 
durchgeführt. Der Follow-iip-Zeitraum lag zwischen 12 und 21 Monaten; eine Plazebokontrollc 
erfolgte nicht. 3 Patienten sprachen auf die Behandlung gut an. In diesen Füllen betrug der 
Behandlungszeitratim 3 bis 6 Monate; bei i Patienten lag RSD im Stadium 1 vor. bei den beiden 
anderen Stadium 2. Die 3 weiteren Patienten zeigten wenig Reaktion. Bei l Palienten war der 
anfängliche Effekt gut, jedoch mußte die Bloekadebehandlung aufgrund eines Infekts im Katheter 
einftihrungs bereich abgebrochen werden. Die beiden anderen Patienten, die auf die Behandlung nur 
wenig ansprachen, wurden 7 bzw. 25 Monate lang behandelt; beide hatten KSD im Stadium. Fs 
wird gefolgert, daß aus theorischer wie klinischer Sieht ein weitere hvalualion der Wirksamkeit der 
Armplexusblockade als ein Behandlungsverfahren in den Frühstadien des RSD ange/eigt ist.
Le blocage du plexus brachial axillaire dans le syndrome de la dy.strophic sympathique 
réflexe
Le syndrome de la dystrophie sympathique rétlexe est un syndrome de douleur neurogène 
caractérisé par le douleur, les chargements vusomoteurs et dystrohiques et souvent les détériorations 
motrices. Cependant la pathogénèse de la DSR est mal connue mais depuis longtemps on a pensé 
que le système nerveux sympathique y joue un rôle déterminant et les sympathectomies 
pharmacologiques et chirurgicales ont été le pivot des soins. Mais, les observations récentes 
montrent le rôle clé des libres nerveuses C et Atf dans Pédologie de la DSR. Ces libres favorisent 
une fonction a la fois sensorielle et effeelueur. lin outre les libres initient des impulsions afférentes 
et libèrent des médiateurs neuropeplides qui provoquent les réactions neuroplastiques centrales et 
une réaction périphérique neurogene inflammatoire, Un blocage du plexus brachial avec les drogues 
anesthésiques empêche la conduction des potentiels d'action a la fois dans les efférentes 
sympathiques et les afférentes somato-sensorielles C et Àô et par conséquent, il semble être un 
traitement potentiel dans le cas de la DSR.
Cette étude avait pour but d'attirer F attention sur cette technique anesthésique peu utilisée dans 
le cas de la DSR. Dans celte élude six malades avec une DSR sévère d ’un membre supérieur mais 
d*un stade évolutif différent * ont subi un traitement avec le ÜPB dans une clinique de réhabilitation, 
en consultation externe, dans un cadre pluridisciplinaire avec un suivi de douze a vingt et un mois. 
Cette étude n ’était pas sous contrôle placebo. Trois malades ont bien réagi aux traitements dans 
ces cas l'intervalle du traitement variait de trois a six mois un des malades était au stade un et les 
deux autres au stade deux de la DSR. Trois malades ont peu réagi dans un de ces v as après une 
bonne réponse initiale le traitement a dû être interrompu a cause d'une mfeetnm locale à 
remplacements du cathéter. Les deux autres cas au stade (rois de la DSR avaient les intervalles 
de traitement de sept et vingt cinq mois.
Nous en concluons qu’il existe des preuves théoriques et clinique, de la valeur des traitements 
BPB et qu'il convient de poursuivre les expériences aux stades précoces de la DSR.
Kl bloqueo del pîexo braquio-nxilar eomo tratamiento del smdnmie de distrnfiu simpâiico* 
relleja
hl sindrome de distroiia simpiüieo-reileja (DSR) es un siiironie neurogënieo doloiosu, caraetetizado 
por dolor, cambios vasomotores y distrôlieos y a rnenudo dehciem tas numuas, Auuqtie se 
desconoee la patogenesis exaeta del DSR, durante demasiado liempo sr pensu que el sistema 
nervioso simpatieo deseinpen| -  |aba un papel prédominante y las simpatectonnas han mdu una base 
para los sistemas de tratamiento. No obstaute, aumeuta la evideneia del papel crucial de las lihras
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( - y Ah cu la etiología tic! DSR. Estas libras sustentan una función s c n s o r i o - e f e c to ni doble. Además 
de iniciar los impulsos aíereules, liberan neuropéptidos mediadores que causan una reacción 
ncurogeniea inflamatoria y reacciones neuroplástieas centrales. El bloqueo del plexo braquial (BPB) 
mediante anestésicos de acción local interliere el paso de los potenciales de acción a través tanto de 
los clórenles del simpático como de los aferentes somatosensorios C- y AS, por lo que parece ser 
una modalidad de tratamiento potencial del DSR. El objeto del presente estudio fue atraer la 
atención hacia esta técnica anestésica regional que no se suele usar en el DSR. El estudio 
comprendió el tratamiento mediante BPB de 6 pacientes en fases diversas de DSR grave de un 
miembro superior, en un establecimiento multidisciplinar de una clínica de rehabilitación 
ambulatoria, con un seguimiento de entre 12 y 21 meses. Tres pacientes respondieron bien. En estos 
casos el intervalo de tratamiento varió de 3 a 6 meses y un caso estaba en la fase 1 del DSR y los 
oíros dos en la lase 2, I ro s  pacientes mostraron respuestas pobres. En uno de ellos el efecto inicial 
fue bueno pero debido a una infección en el lugar de inserción del catéter, el BPB tuvo que 
interrumpirse. 1 ..os otros 2 de respuesta pobre tuvieron intervalos de tratamiento de 7 y 25 meses y 
ambos estaban en la fase 3 del DSR. Nuestra conclusión es que hay una base teórica y clínica para 
serum' evaluando el efecto del BPB como modalidad de tratamiento en las etapas tempranas del
DSR.
Keywords: hrachial plexus bloekade; complex regional pain syndrome, type I; regional anaesthesia; 
re lie x sympathetic dystroplty syndrome; treatment
Introduction
The re líos, sympathetic dystrophy syndrome (RSD) is a neurogenic pain syndrome that is 
eharncUiri/ed by a combination of pain, trophic changes, vasomotor disturbances and 
molor impairments. Most often there is a precipitating factor such as a trivial peripheral 
trauma but also non 'traumatic diseases of the locomotor apparatus, myocardial infarction, 
pleuropulmonary disease and central neurological disorders (e.g. acute stroke and spinal 
cord injury ) may cause RSI) (Tepperman et at,, 1984; Cremer et aL< 1989; Davidoff et <//., 
I9K9; Sehwartzman, 1992). Two extremes of a continuum can be distinguished in the 
clinical course of RSI): the acule stage during which inflammatory signs predominate 
(stage I ) and the chronic stage with atrophy, chronic pain and motor impairments (stage 
Vlhe atropine stage). Stage 2 is classilied as the dystrophic stage (Escobar 1986). The 
different stages are of variable length, do not correspond to different treatment modalities 
and do not occur in a fixed order. RSI) is a descriptive diagnosis with criteria that are not 
unequivocal. Bone scanning can be used lo confirm the clinical diagnosis, in which case 
the three-phase hone scanning technique (TPBS) is the most specific and sensitive 
investigation (Pavidoii et <//., 1989). It antecedes any radiological changes and may be 
used in treatment evaluation. Theories on the pathogenesis of RSD are hypothetical and 
there is little objective evidence on which to base a rational treatment plan. Sympathetic
nerve blocks (sin
a mainstay in tlu
rgieal sympathectomies and regional (Bier or epidural blocks) have been 
* treatment of RSI). As will be discussed laler, the predominant role of the 
sympathetic nervous system in RSI) is subject to debate and there is growing evidence that 
sensitized somatosensory alTcrents (low-threshold A8-meehanoreecptors and C-nocicep- 
tors) arc pivotal in the aetiology of RSI). I his study is aimed at locusing attention on the 
use of axillary brachial plexus blockade (BPB) in RSD. Brachial plexus blockade with 
local a n a e s t h e t i c s  decreases the conduction of both sympathetic efferent fibres and 
somatosensory afierents and therefore seems a potential treatment modality for RSD. The
PB on pain, vasomotor disturbances, range of motion of affected joints and hand 
function was evaluated in six patients with various stages of RSD ol one uppei extiemity.
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After describing the applied methods as well as the individual and general results, the use 
of this regional anaesthetic technique will be discussed within the framework of recent
insights in the pathogenesis of RSD.
Methods
Six patients were studied in the time period from December 1994 until September 1996 
(Table 1). All patients received a standard out-patient rehabilitation programme including 
physical therapy, occupational therapy and psychosocial interventions with a frequency of 
three to five times per week. Moreover, common medical interventions such as pain 
medication, intra-articular injections, radical scavengers (such as dimethyl sulphoxide 
(DMSO) 50% ointment) and vasomediators were administered in individual regimes. BPB 
was added in those patients in which the severity of the pain in the affected extremity was 
so intense that active or passive exercises were not possible.
After standard neurological and orthopaedic physical examination, patients were 
enrolled in the study if they were classified as definite or probable RSD of (a part of) one 
upper extremity according to the diagnostic criteria formulated by Kozin et aL, (1981). 
According to these criteria the diagnosis RSD is considered definite when pain and 
tenderness in the distal extremity are accompanied by swelling and vasomotor instability. 
If pain is accompanied by swelling or vasomotor instability the diagnosis RSD is probable. 
Patients who met the following criteria were excluded: allergy for local anaesthetics, 
immune compromising diseases, haemorrhagic diathesis, severely limited abduction and 
exorotation in the shoulder of the affected arm, lack of cooperation and mental or 
psychiatric disorders. Informed consent with respect to the use of BPB was obtained from 
all patients. Plexus blockade was performed after placing an indwelling catheter within the 
neurovascular sheath. Regional anaesthesia was performed continuously by infusing 
bupivacaine (0.50%, 3 ml/hour) by means of a portable pump (BPB1) or by daily single 
dosis of 20 ml bupivacaine (0.25%) 30 minutes before therapy (BPB2). The BPB-treatment 
was always given for maximally two weeks, after which one week ‘rest5 was given in 
order to prevent complications such as infection and fibrosis. The time period of two 
weeks treatment and one week rest will be referred to as one ‘session’. If necessary these 
sessions were repeated until the pain and other symptoms were reduced to a level that 
allowed active or passive exercises. The choice for BPB1 or BPB2 was a pragmatic one and 
dictated by the availablity of financial support of a pump in the individual cases. The effect 
of the treatment was evaluated by an experienced physician in physical medicine and 
rehabilitation with a follow-up of 12 to 21 months.
Table 1. Patient characteristics
Age Sex Cause Site Stage Treatment
internal“
(months)
1 31 ? Hand surgery (Quervain) Right arm 3 25
2 39 ? Shoulder luxation Left arm 1 2 '
3 41 ? Reconstructive surgery (lesioned 
extensor tendons of the wrist)
Right arm 2 2
4 52 $ Hand surgery (Dupuytren) Right arm 2 3
5 57 $ Bilateral Colies fractures Right hand 2 6
6 41 Î Spontaneous Right arm 3 7
3 Time period passed between diagnosing RSD and first session of brachial plexus anesthesia.
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Results
Patient 1 is a 31-year-old woman who underwent hand surgery because of a morbus 
Quervain of the right hand. Post-operatively the forearm was immobilized with a plaster 
cast for 3 weeks. Alter removal ol the cast the forearm remained swollen, cold and she 
perceived an ongoing burning pain in the entire right arm. She was diagnosed as having 
RSI). At first she was treated with physical therapy, non-steroid anti-inflammatory drugs 
and intra-articular infiltrations with corticosteroids in the wrist. Her complaints persisted 
and in second instance the radical scavenger DMSO (50% ointment) and verapamil (120 
mg daily ) were prescribed without effect. Transcutaneous electrostimulation and amitripty­
line also proved ineffective. The pain persisted and the arm lost all active functions. A 
eock-up splint for the wrist provided some pain relief. One-and-a-half years after onset she 
was referred to our out-patient clinic. At that time, the entire right arm was cold with a 
severe allodynia and an ongoing burning pain that worsened with active or passive 
movement of the arm. Hair and nail growth were increased and skin and muscles were 
atrophied with severe muscle weakness, Contractures were present in the right shoulder, 
elbow, wrist and hand joints, X-ray examination of the hand and wrist showed the typical 
patchy osteoporosis. For two months BPB2 was added to the rehabilitation programme. 
The treatment was aimed at reduction of pain and ischemia and redression of contractures. 
The initial effect was fair both on pain and contracture reduction. Due to local irritation at 
the insertion place the catheter had to be removed after one week. After a replacement of 
the catheter one week later, the effect improved dramatically. Only hours after the 
replacement, the right arm became warm, the pain decreased and the active and passive 
range of motion of the affected joints returned to almost normal. Despite three sessions on 
BPB"'* it was not possible to achieve a definite break through in turning the vicious circle 
of pain and disabilities caused by RSD. All symptoms reoccurred only weeks after the last 
infusion, which remained so during the follow-up period of 14 months.
Patient 2 is a 39-year-old woman who had her first (ideopathic) epileptic seizure, on 
which occasion she traumatized her left shoulder. Fourteen hours after admission to 
hospital a left glenohumeral luxation was recognized and repositioned. After 3 days the left 
arm progressively started to swell and a burning diffuse pain developed. Initially she was 
treated with paracetamol 500 mg 6 times daily, levomepromazine 12.5 mg and 
earbamazepine 300 mg daily. Because there was no treatment effect she was referred to 
our out-patient clinic after six weeks, At that time she suffered from severe allodynia and 
ongoing burning pain in the entire left arm, which was aggravated by any active or passive 
motion. The left arm was swollen, red and warm with hyperhydrosis and could not be 
actively moved. Contractures were developing in the left shoulder and the elbow. The 
ranges of motion of the left hand were severely reduced and painful on examination.
Hlectmneuromyography was performed and revealed minor signs of left brachial plexus 
lesion, in particular impaired motor and sensory conduction velocity ot the ulnar nerve, A 
three-phase hone scanning confirmed the diagnosis RSD. Treatment was started with 
prednison 20 mg daily, DMSO (50% ointment), a cock-up splint for the wrist (during the 
night) and an arm-supporting orthosis to stabilize a minor subluxation in the left 
glenohumeral joint. At several times an intra-articular injection was given in the 
¡eft glenohumeral joint. After one month the effect of this regime was unsatisfying and 
BPB’ was started' Immediately after the first injection of bupivaeaine, there was a
al improvement in pain, swelling as well as active and passive mobility. Hand 
function gradually improved and bimanual activities could be pei formed, Aftei two 
sessions of BPB" a definite tendency towards pain reduction and improvement of hand
stantu
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functions and manual abilities was achieved, also without BPB. The ellects remained
present during a follow-up period of 14 months.
Patient 3 is a 41-year-old woman who cut four extensor tendons at the dorsum of the 
right wrist due to a fall while carrying bottles. After reconstructive surgery her forearm 
was immobilized with a plaster cast. Almost immediately after immobilization the fore­
arm started to swell and it alternately became red and warm or cold and blue. Also, a fierce 
allodynia and ongoing burning pain developed and the cast had to be removed. Active or 
passive exercises were not tolerated due to the severe pain. Initially she was treated with 
the radical scavenger mannitol (10% intravenously, 11 daily) and with verapamil 240 mg 
daily. The mannitol infusion was stopped after one week because of phlebitis. After two 
months this patient was referred to our out-patient clinic because of persisting complaints. 
At that time she suffered from a cold forearm with allodynia, ongoing burning pain, 
oedema, increased hair and nail growth and a dystrophic skin. She was unable to allow any 
active or passive movements of the wrist or lingers. X-ray examination showed a patchy 
osteoporosis of the wrist and the hand. A three-phase bone scanning confirmed the 
diagnosis RSD. Only a few hours after starting BPB1 the right forearm and hand became 
warm, with a substantial reduction in nociception and swelling. Physiotherapy was easily 
tolerated. However due to a local infection at the insertion site of the catheter with 
expansion to a subcutaneous abcess, BPB had to be stopped after three sessions and all 
symptoms reoccurred. During a follow up of 12 months a slight improvement of the 
contractures remained. However, no gain was achieved in the functional use of the hand in 
activities of daily life.
Patient 4 is 52-year-old woman who had undergone surgery for Dupuytren contractures 
in the right hand. After two months she had to be reoperated due to poor functional results. 
After the second operation she developed severe burning pain in the entire right arm 
hindering sleep and household activities and forcing her to stop playing the piano. She was 
referred to our out-patient clinic four months after the second operation. There was some 
oedema in the right hand with hyperpathia and hypoesthesia. Severe contractures were 
present in the right shoulder, wrist and hand joints as well as marked proximal and distal 
muscle weakness. There were no local trigger points in the scar and a possible neuroma 
could be excluded by soft-tissue echoscopy. X-ray examination revealed patchy osteoporo­
sis of the right shoulder and hand and a three-phase bone scan confirmed the diagnosis. 
The right glenohumeral joint was treated with several injections of corticosteroids with 
excellent results. Contracture reduction of the right wrist and hand proved impossible due 
to severe pain. BPB1 was given during three sessions. With this regime she was free of 
pain during therapy sessions and arm and hand function could be restored. Minor 
contractures in the distal and proximal interphalaiigeal joints of the digits III and IV of the 
right hand persisted but muscle strength fully recovered. After 12 months follow-up, this 
patient was not completely satisfied with the outcome because the contractures in digits III 
and IV remained bothersome while playing the piano.
Patient 5 is a 57-year-old woman who sustained bilateral Colics fractures which were 
treated with plaster cast immobilization. The fracture on the right side was complicated by 
a delayed union and the hand remained painful. At first she was unsuccesfully treated with 
physiotherapy and the radical scavenger N-acetyl cysteine 3 times 600 mg daily. Seven 
months after her injury she attended our out-patient clinic with a stage 2 RSI) that was 
confirmed by a three-phase bone scan. The right hand was too painful to be used. Active 
and passive movements were limited due to severe contractures. In order to allow 
mobilization BPB2 was applied during four sessions. There was a major reduction in pain
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as well as in muscle strength. Physiotherapy and finger splinting aimed at contracture
reduction were well tolerated. After two months the pain had disappeared and the
contractures had improved with exception of the digits IV and V. The hand could be used
in all daily life activities and writing. This effect remained present during the follow up 
period of 21 months.
Patient 6 is a 43-year-old woman, already known with a stage 3 RSD of the right leg 
that had developed seven years before. Without a clear cause, the right hand became red, 
warm, swollen and painful. She was diagnosed as RSD and treated with DMSO (50% 
ointment), NSAID, cock-up splint for the wrist, arm sling, regional intravenous 
sympathetic blocks, transcutaneous electrostimulation as well as physical and occupational 
therapy aimed at prevention of contractures and chronic disuse. Because the symptoms did 
not improve she was referred for the BPB trial after seven months. At that time the right 
forearm was cold with allodynia, ongoing burning pain, atrophy of skin, nails and muscles. 
There were slight contractures in the right shoulder and elbow, severe contractures had 
developed in the wrist and hand joints. The hand could not be used in activities of daily 
life. There was an immediate good response to BPB2. The hand became warm, the pain 
subsided, contractures improved and bimanual activities were regained after three sessions 
of BPB2. However, long term effects were disappointing. Only weeks after cessation of 
BPB2 the pain and vasomotor disturbances reappeared, again hindering manual activity. 
After 21 months a slight improvement in pain and contractures remained present but 
bimanual activities were not possible.
General results
Three out of six patients responded poor to treatment. Patient 3 (RSD stage 2, treatment 
interval 2 months, BPB1) showed a good initial response but due to an infection the 
catheter had to be removed. The other two patients with a poor response (patients 1 and 6) 
both had RSD stage 3 and were treated with BPB2 after long treatment intervals 
(respectively 25 months and 7 months). Despite the fact that patient 6 had a stage 3 RSD 
that was irresponsive to sympathectomies and showed poor long term results, BPB2 
initially proved effective in reducing pain, vasomotor disturbances and contractures. Three 
patients responded well. Patient 5 (RSD stage 2, treatment interval 6 months, BPB2) 
showed an excellent immediate response with disappearance of pain and vasomotor 
disturbances, full regainment of handfunction with exception of remaining slight 
contractures in digits IV and V. Patients 4 (RSD stage 2, treatment interval 3 months, 
BPB1) and 2 (RSD stage 1, treatment interval 2 months, BPB2) responded well on all
modalities.
Discussion
During the American Civil War in 1864 Weir Mitchill introduced the term causalgia when 
he described the typical burning pain that followed peripheral nerve injuries from gunshot 
wounds (Mitchell et aU 1864; Mitchell, 1872). In 1916 Leriche described a patient with a 
lesioned brachial plexus nerve in whom resection of the adventitia of the brachial artery of 
the affected arm caused relief of pain (Leriche, 1916). He suspected an important 
pathogenetic role of the sympathetic nervous system in causalgia. Sympathectomies were 
adopted worldwide as first-choice treatment in causalgia without adequate evaluation of 
the effect of this technique (Leriche, 1939). It appeared that many patients with similar 
clinical findings as in causalgia showed no evidence of a vascular or neural lesion and
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many different names such as minqr causalgia, post-traumatic pain syndrome or 
algodystrophy were introduced for this syndrome. Currently, RSD is the most commonly 
used term. Because of the similarities in the clinical presentations of causalgia and RSD, 
sympathectomies were adopted in the treatment of RSD. Again, the physiological 
responses to these interventions remained unclear because of lacking placebo controlled 
studies. Nowadays, the notion of predominant sympathetic involvement in RSD is 
questioned (Dotson, 1993; Ochoa, 1993; Schott, 1995). Sensitized peripheral nociceptors 
(C-afferents) and low-threshold mechanoreceptors (AS-afferents) seem to play a pivotal 
role in RSD and may implicate central mechanisms (Roberts, 1986). Sympathetic activity, 
tissue destruction due to overproduction of toxic free radicals and a neurogenic 
inflammatory reaction all have been suggested to cause nociceptive afference. Firstly, in 
lower vertebrates it has been demonstrated that efferent sympathetic activity modulates 
depolarization of the myelinated A8- and unmyelinated C-cutaneous afferenls (Jiinig, 
1985, 1990). However, microneurography studies show that sympathetic outflow to the 
skin of RSD patients appears normal (Schott, 1995). Furthermore, low venous plasma 
concentrations of noradrenaline in the painful area even suggest sympathetic efferent 
hypofunction (Drummond et al., 1991). Secondly, cell destruction and tissue damage due 
to an overproduction of oxygen free radicals have been suggested as possible underlying 
cause of RSD (Goris et al., 1987). A placebo controlled study on the effect of the radical 
scavanger dimethylsulphoxide (DMSO) 50% in a fatty cream as treatment in RSD supports 
this hypothesis (Zuurmond et al., 1996). Thirdly, it has become evident that a substantial 
portion of primary afferent neurons with C- or AB-libres form a separate subset o f the 
peripheral nervous system. They subserve a dual afferent-efferent function. These sensory- 
effectors are suitable both for afferent impulse initiation to the central nervous system and 
for peripheral and central release of neuropeptide mediators (Scolcsitnyi, 1996). The 
neuropeptide mediators may cause a peripheral neurogenic inflammation (allowing the 
sensory fibres to increase their sensitivity for detecting and responding to adverse 
conditions) and enhance central neuroplastic reactions. Chronic nociceptive afferent 
activity induces transient or long-lasting alterations in membrane excitability as well as 
changes in cellular biochemistry and even structural modification of eytoarchilecture and 
connectivity. These changes may be transneural involving wide dynanamic range (WDR-) 
neurons in the spinal internuncial pool (Roberts, 1986). Sensitized WDR-neurons 
continuously stimulate sympathetic and motor efferent fibres resulting in a vicious self- 
sustaining cycle. Also, it has become evident that transneural changes may spread beyond 
the spinal internuncial pool to other spinal and supraspinal regions (centralization) 
(Ribbers el al., 1995). Within this theoretical framework blocking nociceptive afferenls 
seems a logic procedure as it not only relieves nociception but also prevents centralization. 
Cicala et al. (1990) presented a case in which lumbar sympathetic blocks only temporarily 
eliminated vasomotor disturbances and hyperesthesia in the affected limb, without 
reducing a constant burning pain (Cicala et al. 1990). In contrast, a 72 hours continuous 
epidural block with 0.125% bupivacaine relieved all symptoms. In this concentration 
bupivacaine induces a pharmacologic sympathectomy and relieves nociceptive afference. 
The authors conclude that interruption of a pathologic afferent to efferent nerve conduction 
loop might be responsible for relieving the patients causalgia. Becker et al. (1995) report 
two cases of chronic and therapy resistent RSD that responded well to intrathecal 
morphine infusion by means of an implanted pump (Becker et al., 1995). Only a few 
casuistic reports have outlined the benefits of BPB in RSD and it is not a commonly 
applied technique in RSD. Murray and Atkinson (1995) report a single case in which a
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series of continuous axillary brachial plexus blocks was successfully used in a patient with 
chronic RSD. Earlier case-studies have outlined the benifits of the sequential use of single 
dose blocks (Defalque, 1984; Klein and Klein, 1991).
Like the former studies this study has important methodological shortcomings; it is not 
placebo controlled, the small mumber and heterogeneity of patients allows no statistics and 
it might even be argued that we observed the natural history of the disorder. However, in 
all patients pain and vasomotor disturbances improved within hours after BPB, which 
seems to weaken this argument. Despite the fact that this study does not allow any definite 
conclusions, the results are hopeful. Patients 2, 4 and 5 illustrate that early treatment with 
BPB in otherwise irresponsive cases improves functional outcome. It is hypothesized that 
blocking the somatosensory afferents in an early stage of RSD prevents the process of 
centralization and thereby chronicity. The study of Murray and Atkinson illustrates that
3 also illustrates that blocking somatosensory afferents in a chronic stage can facilitate 
contracture reduction through physical therapy. However, hand function in activities of 
daily life did not improve in this patient. Perhaps this is due to the fact that this patient 
received intermittently administered regional anesthesia with BPB2. Would continuous 
pain reduction with BPB1 have resulted in better functional use of the affected hand in 
activities of daily life and thereby improve long term effect? BPB1 seems more effective 
than BPB2 in interrupting an afferent-efferent vicious circle and in preventing central­
ization and seems first choice when BPB is considered in treating severe RSD of an upper 
exteremity in which active and passive exercises are not tolerated. To prevent the possible 
severe disabilities that may result from RSD, treatment should start as early as possible. 
BPB does not affect the glenohumeral joint. When the glenohumeral joint is involved in 
RSD of an upper extremity intra-articular infiltrations or suprascapular blocks should be 
considered. Furthermore antibiotic prophylaxis may reduce the number of complicating 
infections. Brachial plexus lesions should be documented before BPB is applied in order 
to exclude iatrogenic damage. BPB should not be applied in the case of lack of cooperation 
or insight, in immune compromising diseases or in haemorrhagic diathesis.
Although insights in the pathogenesis of RSD are still hypothetical, a monocausal or 
striclty peripheral origin of this potentially very disabling disorder should be rejected. 
Because of the multiplicity of the mechanisms underlying RSD the treatment of these 
patients remains a challenge and should be performed in multidisciplinary setting. This 
study illustrates that there is theoretical and clinical support that BPB may add to an 
effective multimodal intervention in severe RSD of the upper extremity. However, further 
studies are needed to evaluate this.
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